#
IncuCyte brings live cell imaging to Genea Biocells
Oct 28, 2016
The first application for this technology is FSHD disease modelling and drug discovery.
#
Acceleron to Webcast Overview of ACE-083 Phase 2 Trial
Oct 27, 2016
Webcast to be held Oct 28, 2016 at 10:00 a.m. EDT with Dr. Statland. Archive available on website.
#
Grant Awarded to Develop Outcome Measure
Oct 26, 2016
A proposal to study the histopathological features of muscle in a large biobank from FSHD patients and their first degree family members.
#
Grant Awarded to Explore Innate Immunity
Oct 25, 2016
Development of an in vitro model of FSHD innate immunity.
#
aTyr Pharma ongoing Phase 1b/2 Clinical Trials
Oct 6, 2016
aTyr Pharma, a company engaged in the discovery and development of therapeutics to address severe rare diseases, is currently conducting two trials of Resolaris (ATYR1940) in patients with rare myopathies with an immune component.